Elthera Announces Positive Preclinical Proof of Concept (POC) Studies and Start of New Financing Round."We are very encouraged by these results demonstrating the efficacy of our antibodies in preclinical models of pancreatic and ovarian carcinomas, both areas where a large unmet medical need remains.
More:
prnewswire.com/news-releases/elthera-announces-positive-preclinical-proof-of-concept-poc-studies-and-start-of-new-financing-round-300615395.html
More:
prnewswire.com/news-releases/elthera-announces-positive-preclinical-proof-of-concept-poc-studies-and-start-of-new-financing-round-300615395.html
No comments:
Post a Comment